Skip to main content
. 2018 Aug 10;9:1826. doi: 10.3389/fimmu.2018.01826

Table 3.

Studies of the effect of BTK deficiency on cytokine productions in response to pathogen stimulation.

Cytokine Effect of BTK-deficiency on cytokine production Pathogen used Cell used BTK-deficiency model Cytokine detection Studies Year
Type I IFN Decreased OPV MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
Dengue virus BMDM BTK−/− mice Semiquantitative PCR Lee et al. (23) 2012

No effect H1N1 MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
MoDCs XLA patients ELISA Liu et al. (4) 2012
Listeria monocytogenes BMDM BTK−/− mice Bioassay Köprülü et al. (54) 2013

Type III IFN Decreased OPV MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018

IP-10 Decreased OPV MoDCs XLA patients Flow cytometry Current study 2018
No effect OPV MoDCs LFM-A13 Flow cytometry Current study 2018
H1N1 MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018

IL-1β No effect OPV MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
H1N1 MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018

TNF-α Increased L. monocytogenes BMDM BTK−/− mice ELISA Köprülü et al. (54) 2013
No effect OPV MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
H1N1 MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
(Heat killed) L. monocytogenes BMDM BTK−/− mice ELISA Köprülü et al. (54) 2013

IL-8 No effect OPV MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018
H1N1 MoDCs XLA patients/LFM-A13 Flow cytometry Current study 2018

IL-6 Increased L. monocytogenes BMDM BTK−/− mice ELISA Köprülü et al. (54) 2013
No effect (Heat killed) L. monocytogenes BMDM BTK−/− mice ELISA Köprülü et al. (54) 2013
IL-10 No effect L. monocytogenes BMDM BTK−/− mice ELISA Köprülü et al. (54) 2013

IL-12 Increased L. monocytogenes BMDM BTK−/− mice Flow cytometry (IL12p40) Köprülü et al. (54) 2013
No effect L. monocytogenes BMDM BTK−/− mice ELISA (IL12p70) Köprülü et al. (54) 2013
H1N1 MoDCs XLA patients ELISA Liu et al. (4) 2012

LFM-A13 is a BTK inhibitor. IFN, interferon; IP-10, interferon gamma-induced protein 10; IL, interleukin; OPV, oral poliovirus vaccine Sabine 1; MoDCs, monocyte-derived dendritic cells; BMDM, bone marrow-derived macrophages; XLA, X-linked agammaglobulinemia; BTK, Bruton’s tyrosine kinase.